Therefore, the relevance of IGFBP-2 to metabolic disorder could be a main driver in the investigation of IGFBP-2’s underlying physiological function and may be an important candidate to protect against insulin resistance to diabetes, in obese individuals. The gene discussed is IGFBP2; the disease is diabetes mellitus.